ResMed, Inc. RMD recently introduced its AirCurve 11 series devices ... 11 continue to be more than double that of AirSense ...

Shares of ResMed jumped Friday, making the medical device company the morning's biggest mover on the S&P 500. The stock was recently up nearly 18%. The company last night reported higher fiscal ...

No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

In February 2024, ResMed launched the AirCurve 11 series devices, which expanded its suite of offerings for healthcare ...

ResMed RMD has outperformed the market over the past 10 years by 5.16% on an annualized basis producing an average annual return of 15.88%. Currently, ResMed has a market capitalization of $29.13 ...

To help you find reliable dividend investments, Forbes Advisor has identified 10 of the best dividend stocks available in the U.S. stock market today.

The ResMed Inc (ASX: RMD) share price is avoiding the market selloff and racing higher on Friday. In early trade, the sleep disorder treatment company's shares are up an impressive 10% to $31.50.

SAN DIEGO (AP) — SAN DIEGO (AP) — ResMed Inc. (RMD) on Thursday reported fiscal third-quarter net income of $300.5 million. The San Diego-based company said it had profit of $2.04 per share.

The ResMed Inc. (ASX: RMD) share price is sinking on Friday morning. At the time of writing, the sleep treatment company's shares are down 10% to $30.53. This follows the release of the healthcare ...

Amy Wakeham; Chief IR Officer; ResMed Inc. Brett A. Sandercock; CFO; ResMed Inc. Michael J. Farrell; CEO & Chairman; ResMed Inc. Anthony Charles Petrone; MD & Senior ...

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea ...